1,8-Naphthyridine-derived compounds, the method for the production thereof and the use thereof as agents in the treatment of diseases of the central nervous system caused by a series of processes included in that which is generically known as neurodegeneration. Said diseases may be selected from the list that includes Alzheimer's disease, Parkinson's disease and Huntington's disease.